UCLA Researchers Discover How Drug Binds To Neurons To Stop Drunken Symptoms Of Alcohol
Main Category: Alcohol / Addiction / Illegal DrugsAlso Included In: Rehabilitation / Physical Therapy
Article Date: 11 May 2006 - 13:00 PDT
| Patient / Public: | ![]() |
2.67 (6 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
| Article Opinions: | 1 posts |
UCLA researchers discovered how an experimental drug, called Ro15-4513, binds to specific receptors on brain neurons, which helps explain how this drug stops the drunken behavioral symptoms of alcohol such as impaired motor coordination, memory loss and drowsiness.
The team showed in the lab that Ro15-4513 binds to and blocks alcohol action on these highly alcohol-sensitive receptors. The UCLA group previously found that these receptors are specific subtypes of Gamma-amino butyric acid (GABA-A) receptors that play a role in impairing motor coordination caused by alcohol in experimental animals.
IMPACT: These studies are the first to show how the alcohol antidote drug Ro15-4513 binds to these GABA-A receptors. The research may lead to a better understanding of how alcohol works in the brain as well as help develop drugs that prevent alcohol actions such as a sober-up pill, and alcohol addiction medications and treatments. UCLA researchers also suggest in the future that it may be possible to harness the beneficial effects of alcohol on the body, including inducing sleep, enhancing mood or mirroring the positive effects of moderate alcohol consumption on the heart and brain.
###
AUTHORS: Richard W. Olsen, Ph.D., professor and Martin Wallner, Ph.D., researcher, both in the UCLA Department of Molecular and Medical Pharmacology, are available for interviews.
JOURNAL: The research appears in the May 8 online edition of the Proceedings of the National Academy of Sciences. A PDF of the full study is available.
FUNDING: The study was funded by the National Institutes of Health, the Alcoholic Beverage Medical Research Foundation, and the State of California for medical research on alcohol and substance abuse.
Contact: Rachel Champeau
University of California - Los Angeles
Visit our alcohol / addiction / illegal drugs section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/43047.php>
APA
http://www.medicalnewstoday.com/releases/43047.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Questions more than opinion
posted by Lisa Aofrate on 14 May 2006 at 6:25 pmThe artice on the new drug which attaches itself to certain gamma-etc. receptors, thus reducing or inhibiting adverse reactions to alcohol, was succint, to the point, and worth reading. However, it does not address if and/or when this drug will be approved for human testing. This is what I would be interested in knowing. And, of course, how many years do you estimate FDA approval of such a drug?
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.






